Rumi Igarashi

Immunosuppressive Effects of DTCM-G, a Novel Inhibitor of the mTOR Downstream Signaling Pathway

S. Todo, S. Shibasaki, K. Yamashita, 2013, Transplantation.

Triazolopyrimidine derivative NK026680 and donor-specific transfusion induces CD4+CD25+Foxp3+ T cells and ameliorates allograft rejection in an antigen-specific manner.

S. Todo, M. Murakami, S. Shibasaki, 2020, Transplant immunology.

Immunomodulatory Effect of Nuclear Factor-&kgr;B Inhibition by Dehydroxymethylepoxyquinomicin in Combination With Donor-Specific Blood Transfusion

S. Todo, S. Shibasaki, K. Yamashita, 2012, Transplantation.

3-[(Dodecylthiocarbonyl)Methyl]-Glutarimide Attenuates Graft Arterial Disease by Suppressing Alloimmune Responses and Vascular Smooth Muscle Cell Proliferation

S. Todo, S. Shibasaki, K. Yamashita, 2015, Transplantation.

Functional roles of graft‐infiltrating lymphocytes during early‐phase post‐transplantation in mouse cardiac transplantation models

R. Goto, M. Zaitsu, Rumi Igarashi, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Dendritic Cells Conditioned With NK026680 Prolong Cardiac Allograft Survival in Mice

S. Todo, S. Shibasaki, K. Yamashita, 2012, Transplantation.

NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.

S. Todo, S. Shibasaki, K. Yamashita, 2012, Transplant immunology.

Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice.

S. Akira, K. Takeda, S. Enosawa, 2005, Journal of hepatology.

A NOVEL IMMUNOSUPPRESSIVE AGENT, DTCM-GLUTARIMIDE MARKEDLY PROLONGS CARDIAC ALLOGRAFT SURVIVAL IN MOUSE WHEN COMBINED WITH DONOR SPECIFIC TRANSFUSION: 478

S. Todo, S. Shibasaki, K. Yamashita, 2010 .